CHICAGO--(BUSINESS WIRE)--Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of new oncology treatments, today announces its intention to expedite ...
Key opinion leader (KOL) input is associated with a higher success rate in drug development. However, many oncology programs fail to effectively use this critical resource, resulting in poor decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback